Effect of Oral Cinnamon Intervention in Metabolic Syndrome
- Conditions
- Metabolic Syndrome
- Interventions
- Dietary Supplement: PlaceboDietary Supplement: Cinnamon
- Registration Number
- NCT02455778
- Lead Sponsor
- Diabetes Foundation, India
- Brief Summary
This double blind placebo control study with supplementation of oral Cinnamon is being conducted to test the hypothesis that in subjects with Metabolic Syndrome oral cinnamon may lead to improvement in body composition and metabolic parameters.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 103
-
Subjects aged between 25 -65 years
-
Subjects identified with any three of following:
- Fasting blood glucose ≥100 mg/ dL
- Waist circumference ≥ 90 cm ( males) ≥ 80 cm (females)
- Triglycerides ≥ 150 mg/dL
- High density lipoprotein cholesterol ≤ 40 mg/dL ( in males) , ≤ 50 mg/dL (in females)
- Blood pressure Systolic BP ≥ 130 mm Hg
- Diastolic BP ≥ 85 mm Hg
-
Subjects who were willing to participate in the study.
-
Subjects, if on medication for high blood pressure were stable and there was no change in the dosage for the past 3 months.
- Subjects suffering from other chronic diseases and metabolic complications such as cardiovascular disease, diabetes, renal disease, myocardial infarction and other endocrine disorders.
- Subjects who were allergic to wheat flour and cinnamon.
- Subjects who were on medication of anti dyslipidemic or hypoglycemic drugs.
- Subjects who had undergone bypass procedure.
- Subjects suffering from any debilitating disease such as tuberculosis, HIV etc.
- Subjects suffering from uncontrolled hypothyroidism/ hyperthyroidism
- Pregnant and lactating mothers
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Placebo Placebo 2.5 grams of wheat flour per day in form of capsules ( 6) along with standard diet and exercise protocol Cinnamon Cinnamon 3 grams of oral cinnamon per day in form of capsules (6) along with standard diet and exercise protocol
- Primary Outcome Measures
Name Time Method Fasting Blood Glucose baseline to 4 months
- Secondary Outcome Measures
Name Time Method HbA1c baseline to 4 months Lipid profile baseline to 4 months Body fat percentage baseline to 4 months Blood pressure baseline to 4 months
Trial Locations
- Locations (1)
Fortis-C-DOC Centre of Excellence for Diabetes, Metabolic Diseases and Endocrinology
🇮🇳Delhi, India